Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy

Background: Tuberculosis is a global pandemic which affects millions of people every year. The treatment of tuberculosis consists of simultaneous use of several drugs for a prolonged period of time, therefore anti-tuberculosis treatment induced toxicity is a real problem. It is the most common side...

Full description

Bibliographic Details
Main Authors: Farkhanda Noureen, Abdur Rehman, Asif Hanif
Format: Article
Language:English
Published: Frontier Science Associates 2017-07-01
Series:The International Journal of Frontier Sciences
Subjects:
Online Access:https://publie.frontierscienceassociates.com/index.php/tijfs/article/view/18
id doaj-76635b42efbb4f078305dff762d4b00d
record_format Article
spelling doaj-76635b42efbb4f078305dff762d4b00d2021-09-28T12:12:11ZengFrontier Science AssociatesThe International Journal of Frontier Sciences2618-03592618-03672017-07-011210.37978/tijfs.v1i2.1815Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis TherapyFarkhanda Noureen0Abdur Rehman1Asif Hanif2Gulab Devi Postgraduate Medical Institute Lahore-54600, PakistanGulab Devi Postgraduate Medical Institute Lahore-54600, PakistanGulab Devi Postgraduate Medical Institute Lahore-54600, Pakistan Background: Tuberculosis is a global pandemic which affects millions of people every year. The treatment of tuberculosis consists of simultaneous use of several drugs for a prolonged period of time, therefore anti-tuberculosis treatment induced toxicity is a real problem. It is the most common side effect leading to interruption of therapy. Wide variations have been found in the reported incidence of hepatotoxicity during short-course chemotherapy. This study was conducted to determine the frequency of ATT induced hepatotoxicity in pulmonary TB patients. Methodology: This descriptive, cross-sectional study was conducted at Gulab Devi Chest Hospital Lahore from November 2015 to January 2016. Total 137 pulmonary TB patients were included in this study according to inclusion and exclusion criteria. Data of patients was collected by Questionnaire. Blood samples were taken and LFTs were done. Data was analyzed by using SPSS version 16. Results: Data of 137 patients was taken in the study. Out of which 60 (43.8%) were male and 77 (56.2%) were female. The mean age was 40.59±16.57. 45 (32.8%) patients out of 137, develop hepatotoxicity while 92 (67.2%) shows normal patterns of liver function. 22 (16.1%) patients out of 137 showed elevation of serum bilirubin levels. Conclusion: ATT induced hepatotoxicity is a frequent complication in Pulmonary Tuberculosis patients. So, all patients put on ATT must be followed up for at least the initial month. The patients and the treating physicians must be well-educated about the adverse effects of the ATT, its early recognition and management. https://publie.frontierscienceassociates.com/index.php/tijfs/article/view/18Anti-tuberculosis treatmentpulmonary tuberculosisliver function testshepatotoxicity
collection DOAJ
language English
format Article
sources DOAJ
author Farkhanda Noureen
Abdur Rehman
Asif Hanif
spellingShingle Farkhanda Noureen
Abdur Rehman
Asif Hanif
Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
The International Journal of Frontier Sciences
Anti-tuberculosis treatment
pulmonary tuberculosis
liver function tests
hepatotoxicity
author_facet Farkhanda Noureen
Abdur Rehman
Asif Hanif
author_sort Farkhanda Noureen
title Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
title_short Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
title_full Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
title_fullStr Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
title_full_unstemmed Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
title_sort frequency of hepatotoxicity in pulmonary tuberculosis patients taking anti-tuberculosis therapy
publisher Frontier Science Associates
series The International Journal of Frontier Sciences
issn 2618-0359
2618-0367
publishDate 2017-07-01
description Background: Tuberculosis is a global pandemic which affects millions of people every year. The treatment of tuberculosis consists of simultaneous use of several drugs for a prolonged period of time, therefore anti-tuberculosis treatment induced toxicity is a real problem. It is the most common side effect leading to interruption of therapy. Wide variations have been found in the reported incidence of hepatotoxicity during short-course chemotherapy. This study was conducted to determine the frequency of ATT induced hepatotoxicity in pulmonary TB patients. Methodology: This descriptive, cross-sectional study was conducted at Gulab Devi Chest Hospital Lahore from November 2015 to January 2016. Total 137 pulmonary TB patients were included in this study according to inclusion and exclusion criteria. Data of patients was collected by Questionnaire. Blood samples were taken and LFTs were done. Data was analyzed by using SPSS version 16. Results: Data of 137 patients was taken in the study. Out of which 60 (43.8%) were male and 77 (56.2%) were female. The mean age was 40.59±16.57. 45 (32.8%) patients out of 137, develop hepatotoxicity while 92 (67.2%) shows normal patterns of liver function. 22 (16.1%) patients out of 137 showed elevation of serum bilirubin levels. Conclusion: ATT induced hepatotoxicity is a frequent complication in Pulmonary Tuberculosis patients. So, all patients put on ATT must be followed up for at least the initial month. The patients and the treating physicians must be well-educated about the adverse effects of the ATT, its early recognition and management.
topic Anti-tuberculosis treatment
pulmonary tuberculosis
liver function tests
hepatotoxicity
url https://publie.frontierscienceassociates.com/index.php/tijfs/article/view/18
work_keys_str_mv AT farkhandanoureen frequencyofhepatotoxicityinpulmonarytuberculosispatientstakingantituberculosistherapy
AT abdurrehman frequencyofhepatotoxicityinpulmonarytuberculosispatientstakingantituberculosistherapy
AT asifhanif frequencyofhepatotoxicityinpulmonarytuberculosispatientstakingantituberculosistherapy
_version_ 1716866182178406400